BRCA1 and cancer: In a seminal study that comprehensively classified somatic point mutations and large-scale genomic alterations from 7042 cancers into 20 distinct mutational signatures, ‘signature 3′ was highly associated with BRCA1/2-inactivating mutations [3,137].